Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

6.8K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.8K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

12.4K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.4K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

5.4K
GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.4K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

8.8K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.8K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

812
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
812

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative analysis of ligand binding affinities and functional profiles at recombinant human β-adrenergic receptor subtypes 1, 2, and 3.

The Journal of pharmacology and experimental therapeutics·2026
Same author

Binding affinities for histamine receptors 1 to 4: Systematic comparison of ligands from the Psychoactive Drug Screening Program K<sub>i</sub> database and International Union of Basic and Clinical Pharmacology/British Pharmacological Society Guide to Pharmacology.

Molecular pharmacology·2026
Same author

A new chapter in the history of Naunyn-Schmiedebergs Archives of Pharmacology: appointment of international deputy editors.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Physiological Adaptations and Serum-Based Biomarker Dynamics During Multimodal Rehabilitation in Chronic Pain: Analysis of a Prospective Cohort Study.

Biomolecules·2026
Same author

Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin.

European journal of clinical pharmacology·2026
Same author

A Survey of German Dentists on the Prophylactic Use of Antibacterial Drugs in Patients in Risk Groups: Diabetes, Joint Replacement, Risk of Endocarditis, and Immunosuppression or Organ Transplantation.

International journal of dentistry·2026

Related Experiment Video

Updated: Apr 25, 2026

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
07:15

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)

Published on: July 3, 2025

843

PDE7A1 hydrolyzes cCMP.

Maike Monzel1, Maike Kuhn1, Heike Bähre2

  • 1Institute of Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

FEBS Letters
|August 17, 2014
PubMed
Summary
This summary is machine-generated.

Phosphodiesterase 7A1 (PDE7A1) is the primary enzyme that degrades cyclic pyrimidine nucleotide cyclic cytidine monophosphate (cCMP). PDE7A1 exhibits high-speed, low-affinity hydrolysis of cCMP, distinct from its cAMP activity.

Keywords:
Cyclic CMPCyclic nucleotidesEnzyme kineticsHPLC–MSPhosphodiesteraseSecond messenger

More Related Videos

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

1.1K
Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid
08:49

Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid

Published on: January 26, 2024

725

Related Experiment Videos

Last Updated: Apr 25, 2026

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
07:15

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)

Published on: July 3, 2025

843
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

1.1K
Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid
08:49

Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid

Published on: January 26, 2024

725

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • The biological significance and degradation pathways of cyclic cytidine monophosphate (cCMP) remain poorly understood.
  • Cyclic nucleotides, including cCMP, play crucial roles in cellular signaling pathways.

Purpose of the Study:

  • To elucidate the enzymatic degradation of cCMP.
  • To identify specific phosphodiesterases (PDEs) responsible for cCMP hydrolysis.
  • To characterize the kinetic properties of PDE7A1 towards cCMP.

Main Methods:

  • Recombinant expression and purification of six different phosphodiesterases (PDEs).
  • High-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) for sensitive detection of cCMP.
  • Enzyme kinetic studies using purified truncated PDE7A1.

Main Results:

  • PDE7A1 was identified as the sole enzyme among the tested PDEs capable of significant cCMP hydrolysis.
  • Kinetic analysis revealed a Michaelis constant (KM) of 135 ± 19 μM for cCMP with PDE7A1.
  • The maximum velocity (Vmax) for cCMP hydrolysis by PDE7A1 was 745 ± 27 nmol/(minmg), approximately six times higher than for adenosine 3',5'-cyclic monophosphate (cAMP).

Conclusions:

  • PDE7A1 functions as a high-speed, low-affinity phosphodiesterase specific for cCMP.
  • These findings highlight PDE7A1's potential role in regulating cCMP levels and signaling.
  • Further research is warranted to explore the biological implications of PDE7A1-mediated cCMP degradation.